Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for Cephalic Phase Insulin Secretion in T2D
NCT04227769Phase 2Terminated
- Sponsor
- University Hospital Basel
- Start
- Jan 2020
- Primary completion
- May 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in type 2 diabetes mellitus (T2DM), sponsored by University Hospital Basel. Started Jan 2020; status: terminated.
02
Drugs
anakinra
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04227769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227769.